IHV Annual Marlene and Stewart Greenebaum Lecture
Since 2004, the late Marlene and Stewart Greenebaum sponsored an annual lecture series hosted by the Institute of Human Virology (IHV) at the University of Maryland School of Medicine. Although they have passed, the IHV continues the lecture in their honor.
Each year, IHV's faculty invite leaders in the field of human disease to present this prestigious lecture before IHV and campus leaders, students, faculty and staff.
Speakers include persons who have made substantial scientific contributions and focus on bettering the human condition.
Select a year/lecturer for more information:
2022 - Steven A. Rosenberg, MD, PhD
Steven A. Rosenberg, MD, PhD
Chief, Surgery Branch
National Cancer Institute | NIH
“Lymphocytes as a 'Living Drug' for the Immunotherapy of Cancer”
2019 - Isaac Witz, PhD
Isaac Witz, PhD
Emeritus, Department of Cell Research & Immunology
Tel Aviv University
“Investigating Cancer in Context”
2018 - Anthony S. Fauci, MD
Anthony S. Fauci, MD
Director, U.S. National Institute of Allergy and Infectious Diseases (NIAID)
"Emerging & Re-Emerging Infectious Diseases: The Perpetual Challenge"
2017 - John C. Martin, PhD
John C. Martin, PhD
Chairman & Chief Executive Officer, Gilead Sciences, Inc.
"Research on Nucleotide Analogues has led to Major Advances in Antiviral Therapy"
2016 - Paul A. Volberding, MD
Paul A. Volberding, MD
Professor of Medicine, University of California San Francisco (UCSF)
Director, AIDS Research Institute
Director of Research, UCSF Global Health Sciences
Co-Director, UCSF-GIVI Center of AIDS Research
"The Arc of the AIDS Epidemic: From the Beginning to the Beginning of the End"
2015 - King K. Holmes
King K. Holmes, MD, PhD
Director of Research and Faculty Development
Department of Global Health
Professor of Global Health and Medicine
University of Washington
"What You Need to Know About the STIs that are Most Likely to be Fatal"
2013 - David Quammen
Renowned Science Writer
"Spillover: The Animal Origins of Human Infectious Disease, and the Search for the Next Big One"
2012 - Diane E. Griffin, MD, PhD
Diane E. Griffin, MD, PhD
Alfred and Jill Sommer Professor and Chair in Molecular Microbiology and Immunology,
Johns Hopkins Bloomberg School of Public Health,
The Johns Hopkins University
"Virus Clearance: It Isn’t Easy"
2011 - Reinhard Kurth, MD
Reinhard Kurth, MD
Emeritus Professor and Former Director, Robert Koch Institute, Berlin
Former Director, Paul Ehrlich Institute, Frankfurt
Co-founder, Global Virus Network
"The Viruses in All of Us: Functions of Human Endogenous Retroviruses"
2010 - Bernadine Healy, MD
Bernadine Healy, MD
Former Director, U.S. National Institutes of Health
Former Director, American Heart Association
Former Director, American Red Cross
"The Noble Mission: Science on Behalf of Human Health"
2009 - Max Essex, DVM, PhD
Max Essex, DVM, PhD
Lasker Professor of Health Sciences at Harvard University
Chair, Harvard School of Public Health AIDS Initiative
Chair, Botswana Harvard AIDS Institute Partnership
"The HIV Epidemic in Southern Africa: Treatment for Prevention"
2008 - William A. Haseltine, PhD
William A. Haseltine, PhD
President, Haseltine Foundation for Medical Sciences and the Arts
Former Professor, Harvard Medical School
"Biomedical Science in a Changing World"
2007 - Sir Gustav Nossal
Sir Gustav Nossal
Professor Emeritus, The University of Melbourne (Australia)
Former Director, The Walter and Eliza Hall Institute of Medical Research
"The Twenty First Century: A turning Point in Global Health Reform"
2006 - J. Donald Capra, MD
J. Donald Capra, MD
President Emeritus, Oklahoma Medical Research Foundation
"The Independent Biomedical Research Institute in America: A Private/Public Success Story"
2005 - Andrew von Eschenbach
Andrew von Eschenbach, MD
Director, U.S. National Cancer Institute
"Eliminating the Suffering and Death Due to Cancer by 2015"
2004 - Richard D. Klausner, MD
Richard D. Klausner, MD
Executive Director, Global Health, Bill & Melinda Gates Foundation
Former Director, U.S. National Cancer Institute
"Grand Challenges in Global Health"